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Oncogenic transformation of cells alters their morphology, cytoskeletal organization, and
adhesive interactions. When the mammary epithelial cell line MCF10A is transformed by
activated H-Ras, the cells display a mesenchymal/fibroblastic morphology with decreased
cell–cell junctions but increased focal adhesions and stress fibers. We have investigated
whether the transformed phenotype is due to Rho activation. The Ras-transformed MCF10A
cells have elevated levels of myosin light chain phosphorylation and are more contractile
than their normal counterparts, consistent with the activation of Rho. Furthermore, inhibitors
of contractility restore a more normal epithelial phenotype to the Ras-transformed MCF10A
cells. However, inhibiting Rho by microinjection of C3 exotransferase or dominant negative
RhoA only partially restores the normal phenotype, in that it fails to restore normal junctional
organization. This result prompted us to examine the effect that inhibiting Rho would have
on the junctions of normal MCF10A cells. We have found that inhibiting Rho by C3
microinjection leads to a disruption of E-cadherin cytoskeletal links in adherens junctions and
blocks the assembly of new adherens junctions. The introduction of constitutively active Rho
into normal MCF10A cells did not mimic the Ras-transformed phenotype. Thus, these results
lead us to conclude that some, but not all, characteristics of Ras-transformed epithelial cells
are due to activated Rho. Whereas Rho is needed for the assembly of adherens junctions, high
levels of activated Rho in Ras-transformed cells contribute to their altered cytoskeletal
organization. However, additional events triggered by Ras must also be required for the
disruption of adherens junctions and the full development of the transformed epithelial
phenotype.
INTRODUCTION
Oncogenic transformation often results in epithelial
cells losing many of their distinctive epithelial charac-
teristics. Transformed epithelia frequently lose their
polarized morphology, reveal less organized cell–cell
junctions, and become more migratory (Behrens et al.,
1989; Birchmeier et al., 1993). In many ways, these cells
appear more mesenchymal. One of the commonest
oncogenes to be activated in human cancers is Ras
(Slamon et al., 1984; Thor et al., 1986; Clark and Der,
1995). This low molecular weight GTP-binding protein
has been shown to be involved in multiple signaling
pathways, the best characterized being the Raf/mito-
gen-activated protein kinase (MAPK) cascade (Rob-
erts, 1992; Marshall, 1996). This pathway ultimately
affects gene expression. Ras is also involved in regu-
lating the organization of the actin cytoskeleton, with
Rho and Rac being downstream effectors (Hall, 1994).
In addition, there are several other effectors found to
be associated and regulated by Ras, such as phospha-
tidylinositol 3-kinase and Ral guanine nucleotide dis-
sociation stimulator (Rodriguez-Viciana et al., 1994;
Spaargaren and Bischoff, 1994; Marshall, 1996). Stud-
ies from several groups have indicated that oncogenic
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Ras activation of pathways in addition to the Raf/
MAPK pathway, such as those involving Rac and Rho,
are essential for tumorigenic transformation of both
fibroblasts and epithelial cells (Khosravi-Far et al.,
1995, 1996; Prendergast et al., 1995; Qiu et al., 1995a,b;
Oldham et al., 1996).
As a model to better understand how activated Ras
may transform epithelial cells, we have used MCF10A
breast epithelial cells transfected with either normal
H-Ras or oncogenically activated H-Ras (12V; Basolo et
al., 1991). The Ras-transformed MCF10A cells appear
more mesenchymal (fibroblastic) in their morphology,
in the organization of their cell–cell junctions and
their actin cytoskeletons (Kinch et al., 1995). Whereas
normal MCF10A cells grow in culture as tightly clus-
tered epithelial colonies, the Ras-transformed
MCF10A cells are more loosely arranged. The normal
MCF10A cells reveal circumferential bundles of actin
filaments, typical of polarized epithelia. In contrast,
the Ras-transformed MCF10A cells possess large bun-
dles of actin filaments (stress fibers) that extend across
the cells and terminate in focal adhesions (Kinch et al.,
1995). This latter type of junction is generally absent
from the normal MCF10A cells in culture, except at the
periphery of a colony or when the MCF10A cells are
growing without contact with their neighbors. The
prominent stress fibers and focal adhesions of Ras-
transformed MCF10A cells are reminiscent of cells in
which the Ras family member Rho has been activated
(Ridley and Hall, 1992). Rho stimulates the assembly
of focal adhesions and stress fibers by increasing the
contractility of cells (Chrzanowska-Wodnicka and
Burridge, 1996). Herein we have investigated whether
the fibroblastic phenotype of Ras-transformed epithe-
lial cells is due to activation of Rho and, in particular,
due to the stimulation of contractility. A portion of this
work has been presented (Zhong et al., 1996).
MATERIALS AND METHODS
Cell Culture
MCF10A cells originated from a spontaneous immortalization of
mammary tissue from a patient with fibrocystic disease were trans-
fected with the normal human H-Ras protooncogene (N) or with the
12V-mutated form of H-Ras oncogene (T) and maintained in DMEM
and Ham’s F-12 medium (1:1, vol/vol) containing 5% horse serum,
20 ng/ml epidermal growth factor, 10 mg/ml insulin, and 0.5 mg/ml
hydrocortisone under a 5% CO2, 95% air atmosphere (Soule et al.,
1990; Basolo et al., 1991). Subconfluent dishes were treated with
various reagents for 1 to 2 h and later were either lysed with lysis
buffer (see below) for biochemical assays or trypsinized and plated
on coverslips for immunofluorescence study. Contractility was as-
sayed with cells plated on silicone rubber substrates overnight at
high density as described previously (Harris et al., 1980) with some
modifications (Chrzanowska-Wodnicka and Burridge, 1996). To en-
sure better adhesiveness of cells to the substrate, dishes covered
with silicone rubber substrates were further coated with palladium/
gold by using a cold sputter coater for 16 s in .99% argon-filled
chamber. The evenly distributed metal surface makes the cells ad-
here and spread more quickly.
Reagents and Antibodies
KT5926 (Calbiochem, La Jolla, CA; Nakanishi et al., 1990) was used
at 60 mM; 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine (Sigma,
St. Louis, MO) was used at 150 mM (Chrzanowska-Wodnicka and
Burridge, 1996); 2,3-butanedione 2-monoxime (BDM, Sigma) was
used at 20 mM (Higuchi and Takemori, 1989; Hermann et al., 1993;
Osterman et al., 1993; McKillop et al., 1994; Chrzanowska-Wodnicka
and Burridge, 1996); ML-7 (Biomol, Plymouth Meeting, PA) was
used at 25 mM (Saitoh et al., 1987). Drugs were either dissolved in
dimethyl sulfoxide or culture medium as stock solution stored at
220°C and diluted right before use. Mouse monoclonal antibody
specific for E-cadherin was purchased from Transduction Labora-
tories (Lexington, KY). Monoclonal rat anti-E-cadherin (DECMA)
was obtained from Sigma. A monoclonal antibody against vinculin
(7F9) was a gift from Dr. A. Belkin (Glukhova et al., 1990). A
monoclonal antibody against paxillin was from Dr. J. Glenney
(Turner et al., 1990). Fluorescein- or rhodamine-conjugated phalloi-
din was purchased from Molecular Probes (Eugene, OR). C3 exo-
transferase was purchased (Upstate Biotechnology, Lake Placid,
NY) or made in the laboratory as a glutathione S-transferase (GST)
fusion protein (see below; Aktories and Hall, 1989).
Immunofluorescence Microscopy
Cells plated on coverslips were fixed with 3.7% formaldehyde in
PBS and permeabilized with 0.5% Triton X-100 as described else-
where (Kinch et al., 1995). Cells were incubated with the primary
antibodies and then rhodamine-conjugated goat anti-mouse or don-
key anti-rabbit antibodies (Chemicon International, el Segundo, CA)
for 30 min, respectively, before being mounted and viewed on an
Axiophot microscope (Carl Zeiss, Thornwood, NY). Fluorescence
micrographs were taken on T-Max 400 film (Eastman Kodak, Roch-
ester, NY). To visualize molecules associated with the actin cy-
toskeleton, cells were permeabilized with 0.5% Triton X-100 first,
followed by fixation and incubation with the primary antibodies.
Metabolic Labeling, Immunoprecipitation, SDS-
PAGE, Western Blot, and Autoradiography
In some experiments, cells were metabolically labeled with 160
mCi/ml Translabel (a mixture of [35S]methionine and [35S]cysteine;
ICN Biomedicals, Irvine, CA) in methionine-free medium contain-
ing 1% fetal calf serum, 2 mM glutamine, and all other components
required for MCF10A cells. After labeling, cells were washed four
times with PBS. Cells were then lysed with RIPA buffer containing
1% deoxycholate acid, 0.5% Triton X-100, 0.1% SDS, 1 mM phenyl-
methylsulfonyl fluoride, 1 mM benzamidine, 10 mg/ml leupeptin,
and 10 mg/ml aprotinin, and the total amounts of de novo-synthe-
sized proteins in different samples were measured by using an
LS5000CE scintillation counter (Beckman, Palo Alto, CA). For my-
osin light chain phosphorylation assay, cells were double-labeled
with 35S and 32P as described previously (Chrzanowska-Wodnicka
and Burridge, 1996). Myosin light chain was separated by SDS-
PAGE on 15% gels. In all cases, protein bands were either viewed by
autoradiography or PhosphorImager (Molecular Dynamics, Sunny-
vale, CA) and the intensity of light chain phosphorylation was
represented as the ratio of 32P in the light chains relative to 35S in the
heavy chains. To study the cytoskeletal association of E-cadherin,
cells were sequentially extracted first with 0.5% digitonin in a buffer
containing 20 mM Tris(hydroxymethyl)aminomethane hydrochlo-
ride, 100 mM NaCl, 0.5 mM ethylene glycol-bis(b-aminoethyl
ether)-N,N,N9,N9-tetraacetic acid, and 1 mM MgCl2 and then with
RIPA buffer. Cell lysates were immunoprecipitated with DECMA
and 10% protein A-Sepharose to which had been bound anti-rat
IgG, separated on 10% polyacrylamide gels as described (Laemmli,
1970) with bisacrylamide concentration of 0.13%, and probed by
monoclonal anti-E-cadherin antibody (Transduction Laboratories).
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Microinjection of Fusion Proteins and Plasmids
Recombinant 14V RhoA and C3 (gifts from Dr. A. Hall, University
College, London, UK, and Dr. L. Feig, Tufts University, Boston, MA,
respectively) were expressed as GST fusion proteins in Escherichia
coli. Expression of the fusion proteins was induced by isopropyl
b-d-thiogalactopyranoside (Boehringer, Mannheim, Germany) and
bacteria were lysed by sonication at 4°C. The fusion proteins were
further purified with glutathione-agarose beads (Pharmacia, Pisca-
taway, NJ). For 14V RhoA preparation, protein was released by
triple elution with 25 mM reduced glutathione, pH 8.0. For C3,
protein was cleaved by thrombin (Sigma) and all the unused throm-
bin was removed by incubation with 50% p-aminobenzamide beads.
Both proteins were dialyzed against microinjection buffer contain-
ing 50 mM Tris(hydroxymethyl)aminomethane, pH 7.5, 50 mM
NaCl, 5 mM MgCl2, and 0.1 mM dithiothreitol and concentrated to
1–2.5 mg/ml for 14V RhoA and 100 mg/ml for C3 before microin-
jection. GST protein alone was generated as above to serve as a
control. Cells plated on coverslips were microinjected by using the
method described by Graessmann et al. (1980). Control injections
were performed by using GST alone or bovine serum albumin (BSA)
in the same microinjection buffer. Cells were injected for 15 to 30
min and then returned to the incubator for another 30 min to 7 h, as
needed for different experiments. Injected cells were visualized by
the coinjection of coumarin-conjugated BSA or by staining with an
anti-GST polyclonal antibody followed by rhodamine-conjugated
donkey anti-rabbit IgG or coinjection of 1 mg/ml propidium iodide
(Sigma). Propidium iodide labels DNA in the nuclei of injected cells
and was particularly useful when cells were permeabilized before
fixation because the label was not lost with permeabilization.
For nuclear injection, plasmids were diluted in an injection buffer
containing 5 mM potassium glutamate (Fluka, Buchs, Switzerland)
and 130 mM KCl. Cells plated on coverslips were injected with
plasmid pGreen Lantern either alone (20 mg/ml, Life Technologies,
Gaithersburg, MD) or together with 19N-RhoA plasmid at a final
concentration of 30 mg/ml (kindly provided by Dr. Marc Symons,
Onyx Pharmaceuticals, Richmond, CA). Twenty-four hours later
cells were fixed and stained. Microinjected cells were visualized by
the expression of green fluorescent protein in the cytoplasm.
Proliferation and Motility Assays
To measure DNA synthesis, cells plated on coverslips were incubated
with 100 mM 5-bromo-29-deoxyuridine (BrdUrd, Sigma) for 24 h, fixed,
permeabilized, and stained with an anti-BrdUrd monoclonal antibody
(Sigma). Cell nuclei were visualized by staining with Hoechst dye. For
motility assays, MCF10A cells were plated at low density onto 35-mm
tissue culture dishes (Costar, Cambridge, MA) and incubated over-
night in growth medium. Next day the medium was supplemented
with 20 mM N-(2-hydroxyethyl)piperazine-N9-(2-ethanesulfonic acid)
and all the following steps were done with the dishes on a microscope
stage maintained at 37°C. Cell movement was then recorded with a
time-lapse video recorder with a 60-fold time compression. The rates of
cell motility were calculated by measuring the displacement of indi-
vidual cells over a 2-h period.
RESULTS
Ras-transformed MCF10A Cells Reveal Increased
Contractility That Is Rho Dependent
Previous work from this laboratory has demonstrated
that RhoA activation is associated with increased con-
tractility (Chrzanowska-Wodnicka and Burridge,
1996). To determine whether the Ras-transformed
MCF10A cells revealed increased contractility com-
pared with their normal counterparts, these cells were
plated on flexible silicone-rubber substrates. These
flexible substrates develop wrinkles in response to
tension generated by cells adhering to them. Normal
MCF10A cells usually developed few wrinkles (Figure
1A) and those that were developed tended to extend
across large areas of confluent cells, indicating that the
tension was being generated by islands of epithelia. In
contrast, the Ras-transformed MCF10A cells generated
many more small wrinkles in the underlying rubber
substrates (Figure 1B). These wrinkles could often be
seen to be generated by single cells. Because activation
of Rho could lead to elevated phosphorylation of the
regulatory myosin light chains (Amano et al., 1996;
Chrzanowska-Wodnicka and Burridge, 1996; Kimura
et al., 1996) and myosin light chain phosphorylation
has been shown to be involved in the activation of
contractility of smooth muscle and nonmuscle cells
(Craig et al., 1983; Kolodney and Elson, 1993; Goeck-
eler and Wysolmerski, 1995), we examined the state of
myosin light chain phosphorylation in the Ras-trans-
formed MCF10A cells compared with the nontrans-
formed parental cells. The Ras-transformed cells re-
vealed elevated myosin light chain phosphorylation
(Figure 1C), consistent with increased contractility and
activation of Rho. To further determine whether Rho
was involved in causing the tension on the underlying
substratum, Ras-transformed MCF10A cells were
plated on silicone rubber substrates under subconflu-
ent conditions overnight. Cells that were actively
wrinkling the rubber (Figure 2A) were microinjected
with the C3 exotransferase which ADP-ribosylates
and inactivates Rho (Figure 2B, arrowheads). The be-
havior of the cells was followed by time-lapse video-
microscopy. Within about 5 min of microinjection of
the C3 exotransferase, the wrinkles started to be re-
leased (Figure 2C) and were greatly decreased in less
than 10 min (Figure 2D). Similar cells injected with
control proteins or buffer alone did not release the
wrinkles (our unpublished observations).
Inhibition of Contractility Restores a More Normal
Epithelial Phenotype to the Ras-transformed
MCF10A Cells
The formation of stress fibers and focal adhesions has
been attributed to the development of isometric ten-
sion (Burridge, 1981; Burridge and Chrzanowska-
Wodnicka, 1996; Chrzanowska-Wodnicka and Burr-
idge, 1996). We wished to determine whether blocking
contractility and the development of tension would
not only inhibit the formation of stress fibers and focal
adhesions in the Ras-transformed epithelial cells but
would also restore more normal cell–cell junctions.
Several inhibitors of contractility were used in this
study, including inhibitors of MLCK (KT5926 and ML-
7), an inhibitor of myosin ATPase activity and, there-
fore, myosin–actin interaction (BDM) and the broad
spectrum kinase inhibitor 1-(5-isoquinolinylsulfonyl)-
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2-methylpiperazine, which has previously been
shown to inhibit both fibroblast and epithelial contrac-
tility (Volberg et al., 1994; Chrzanowska-Wodnicka
and Burridge, 1996). All of these inhibitors were effec-
tive in blocking the contractility of the Ras-trans-
formed MCF10A cells in a dose-dependent manner, as
judged by the release of wrinkles generated by these
cells growing on silicone rubber substrates. This is
shown for Ras-transformed MCF10A cells treated
with either 20 mM BDM (Figure 3B) or 25 mM ML-7
(Figure 3C). If these inhibitors were removed, wrin-
kling of the substrate was restored within 1 h, indicat-
ing that the effects were reversible (Figure 3D). We
also examined the action of these inhibitors on the
organization of the actin cytoskeleton and on focal
adhesions and adherens junctions (Figures 4 and 5). At
concentrations that inhibited the wrinkling of the rub-
ber substrates, the inhibitors had a striking effect on
stress fibers, focal adhesions, and adherens junctions.
The prominent focal adhesions of the Ras-transformed
MCF10A cells were greatly decreased by the inhibitors
of contractility as revealed by vinculin (Figure 4, C, E,
and G) and paxillin staining (Figure 4, D, F, and H).
Few, if any focal adhesions were seen in many cells,
particularly within the center of colonies. Cells with
free borders revealed some focal adhesions, but these
were typically small and confined to the free margin of
the cells. Similarly, stress fibers were abolished and
the actin became organized into circumferential bun-
dles that resembled the organization of actin in the
normal MCF10A cells (Figure 5, B, D, F, and H). More-
over, the inhibitors of contractility resulted in a
marked restoration of adherens junctions between ad-
jacent cells. This was revealed by the distribution of
both vinculin (Figure 4, A, C, E, and G) and E-cadherin
(Figure 5, A, C, E, and G). The borders of adjacent cells
became tightly defined, as judged by staining with
antibodies against vinculin and E-cadherin, in contrast
to the “jagged” or discontinuous staining pattern that
was often noted for the untreated Ras-transformed
MCF10A cells. By using [35S]methionine-labeled cells
and BrdUrd incorporation, BDM and ML-7 showed no
significant effects on protein synthesis or cell prolifer-
ation, although we found a significant decrease in the
Figure 1. Ras-transformed MCF10A cells reveal increased contrac-
tility. Normal (A) and Ras-transformed (B) MCF10A cells were
cultured on flexible silicone rubber substrates and visualized by
phase microscopy. The Ras-transformed cells exerted sufficient ten-
sion on the underlying rubber to generate wrinkles (B). Bar, 200 mm.
(C) The levels of myosin light chain phosphorylation in the normal
and Ras-transformed cells were compared.
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motility of single Ras-transformed MCF10A cells after
treatment with these contractility inhibitors (our un-
published observations).
Because E-cadherin binds to the actin cytoskeleton
via b-catenin and a-catenin in stabilized cell–cell ad-
herens junctions and becomes detergent insoluble
(Hinck et al., 1994; Ewing et al., 1995; Takeichi, 1995),
the effect of contractility inhibitors on the detergent
solubility of E-cadherin was also examined. Com-
pared with their normal counterparts, the Ras-trans-
formed MCF10A cells revealed that a significant frac-
tion of E-cadherin was soluble after permeabilization
with buffers containing nonionic detergents (Kinch et
al., 1995; Figure 6, T digitonin). Interestingly, when the
Ras-transformed MCF10A cells were treated with in-
hibitors of contractility, almost all the E-cadherin was
driven back into the detergent-insoluble cytoskeleton-
associated pool, suggesting that cell–cell adherens junc-
tions were restored to a more normal state (Figure 6).
Inhibition of Rho Activity Partially Restores a
More Normal Epithelial Phenotype
Because contractility is partly regulated by Rho and
inhibition of contractility leads to restoration of adhe-
rens junctions, we were interested whether inhibition
of Rho directly could restore adherens junctions in
Figure 2. Rho activity contributes to the increased contractility of Ras-transformed MCF10A cells. Ras-transformed MCF10A cells were
cultured on silicone rubber substrates at high density. A–D are images of successive time points from a video recording of cells microinjected
with the Rho-inhibitor C3. Cells before injection are seen in A. B shows the cells at the time of injection. Cells were injected with C3 on the
right side of the field and are indicated with arrowheads. Within 4.5 min after injection (C), many of the wrinkles in the rubber have
decreased. This decrease in wrinkling is more pronounced at about 9 min after injection (D).
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Ras-transformed cells. The activity of Rho was inhib-
ited in the Ras-transformed MCF10A cells by micro-
injection of the C3 exotransferase (160 mg/ml) into
these cells. By some criteria, C3 mimicked the action of
the inhibitors of cell contractility. C3 caused the dis-
assembly of focal adhesions (Figure 7C) and stress
fibers (our unpublished observations). When the dis-
tribution of vinculin was examined (Figure 7C), it
appeared to indicate the reformation of more normal
continuous adherens junctions. However, this conclu-
sion was not supported when the organization of E-
cadherin was studied in C3-treated cells (Figure 7E).
This indicated that E-cadherin-based adherens junc-
tions had not reformed. The staining for vinculin was
detected not only at sites of cell–cell contact but also
along the free borders of the C3-injected cells. This
organization is reminiscent of the “focal complexes”
detected at the margins of lamellipodia in cells in
which Rho has been inhibited by C3 treatment but in
which Rac has been activated (Ridley and Hall, 1992;
Nobes and Hall, 1995).
Because C3 has been criticized for its potential tox-
icity, we also explored the use of dominant negative
Rho. Expression of dominant negative RhoA (19N-
RhoA) in the Ras-transformed MCF10A cells led to a
loss of focal adhesions as judged by vinculin staining
(Figure 8D). However, vinculin was not seen in cell–
cell junctions or at the margins of cells expressing
dominant negative RhoA.
Figure 3. BDM and ML-7 are potent inhibitors of contractility in Ras-transformed MCF10A cells. Ras-transformed MCF10A cells plated on
silicone rubber substrates were either untreated (A) or treated with 20 mM BDM (B) or 25 mM ML-7 (C) for 1 h. The effects of both inhibitors
were reversible. (D) Cells were exposed to 20 mM BDM for 1 h and then treated with normal medium for another 1 h. Bar, 200 mm.
Figure 4 (facing page). Inhibition of contractility abolishes focal
adhesions in Ras-transformed MCF10A cells. Normal MCF10A cells
(A and B) or MCF10A cells transformed (T) by oncogenic H-Ras
(C–H) were untreated (C and D) or treated either with 20 mM BDM
(E and F) or 25 mM ML-7 (G and H) for 2 h. Cells were fixed and
stained with vinculin (A, C, E, and G) or paxillin (B, D, F, and H). (A,
E, and G) Arrowheads indicate vinculin that is in adherens junc-
tions. (C and D) Arrowheads indicate vinculin or paxillin in prom-
inent focal adhesions within confluent regions of the culture. After
treatment with contractility inhibitors, the number and size of focal
adhesions in Ras-transformed MCF10A cells within confluent areas
are diminished. Bar, 20 mm.
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Figure 4.
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Figure 5.
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Introduction of Activated Rho into Normal MCF10A
Cells Is Insufficient to Induce the Ras-transformed
Phenotype
Because Rho is upstream of contractility and because
many of the phenotypic characteristics of the Ras-
transformed cells could be reversed by inhibition of
Rho or inhibition of contractility, we asked whether
introduction of constitutively active Rho into normal
MCF10A cells would induce the morphological and
cytoskeletal effects of the Ras-transformed phenotype.
Subconfluent normal MCF10A cells were microin-
jected with constitutively active 14V Rho and analyzed
at times from 30 min to 7 h for the development of
stress fibers and other morphological characteristics
consistent with the Ras-transformed phenotype. The
cells injected with activated Rho often stained very
brightly with phalloidin, consistent with increased ac-
tin polymerization. The cells appeared contracted
(Figure 9C), whereas cells injected with buffer alone
did not (Figure 9A). Frequently, the contracted cells
exhibited retraction fibers that stained strongly with
phalloidin. However, distinct stress fibers and focal
adhesions were not detected. Within short periods of
time (,30 min), 14V Rho did not affect cell–cell junc-
tions (our unpublished observations). It was difficult
to distinguish the state of adherens junctions at longer
periods of time after microinjection, because the in-
jected cells tended to round up, while remaining at-
tached, probably reflecting their highly contracted
state.
Rho Activity Is Required for Cell–Cell Adherens
Junction Formation and Maintenance
The inability of activated Rho to disrupt adherens
junctions in normal MCF10A cells and the fact that the
C3 did not restore the adherens junctions of Ras-
transformed MCF10A cells led us to ask whether Rho
may actually have a role in the formation of adherens
junctions. The relationship of Rho to adherens junc-
tions was examined in cells that already had devel-
oped these structures and in cells that were in the
process of assembling cell–cell junctions. Normal
MCF10A cells that had been confluent for 2 d were
microinjected with C3 and then examined at various
time points for the state of adherens junction forma-
tion as judged by staining with an antibody against
E-cadherin. Injected cells were revealed by including
propidium iodide in the injection buffer to label the
nuclei of the injected cells. Cells that had not been
injected or had been injected with control proteins
revealed the normal epithelial organization of E-cad-
herin (Figure 10A); E-cadherin was observed in a
smooth continuous pattern at cell–cell contact sites
after detergent extraction. Staining was absent from
free borders. After introduction of C3, there was a
deterioration of the E-cadherin staining pattern
(Figure 10B). This was more obvious in cells that
were first extracted with detergent (0.5% Triton X-
100) before fixation and staining. The increased ex-
traction of E-cadherin in nonionic detergents after
C3 injection indicated that E-cadherin was less as-
sociated with the cytoskeleton, was failing to inter-
act with E-cadherin molecules on the surface of
adjacent cells, or both.
To examine the effect of inhibiting Rho activity on
the assembly of adherens junctions, C3 was injected
into normal MCF10A cells that lacked adherens junc-
tions due to chelation of extracellular calcium. In nor-
Figure 6. BDM and ML-7 drive E-cadherin into the detergent-
insoluble fraction of Ras-transformed MCF10A cells. Monolayers of
normal MCF10A (N), Ras-transformed MCF10A (T), Ras-trans-
formed cells treated with either 20 mM BDM (BDM) or 25 mM ML-7
(ML-7) for 2 h were sequentially extracted with 0.5% digitonin and
modified RIPA buffer. Total amount of protein in each sample was
equalized before immunoprecipitation. All the fractions were im-
munoprecipitated with anti-E-cadherin antibody and immuno-
blotted for E-cadherin.
Figure 5 (facing page). Inhibition of contractility restores more
normal cell–cell adherens junctions and cytoskeletal organization to
Ras-transformed MCF10A cells. Normal MCF10A cells (A and B) or
MCF10A cells transformed (T) by oncogenic H-Ras (C–H) were
untreated (C and D) or treated either with 20 mM BDM (E and F) or
25 mM ML-7 (G and H) for 2 h. Cells were stained for E-cadherin
after permeabilization (A, C, E, and G) and stained for actin (B, D,
F, and H). Arrowheads in A, E, and G mark prominent adherens
junctions. In contrast the arrowhead in C indicates a region of
cell–cell contact in the untreated Ras-transformed cells exhibiting
little E-cadherin staining. The arrowhead in D indicates actin orga-
nized in stress fibers, which are absent from the cells in B, F, and H.
Bar, 20 mm.
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mal circumstances, restoration of calcium stimulates
the rapid assembly of adherens junctions. Cells micro-
injected with C3 and returned to high calcium to in-
duce reassembly of adherens junctions were unable to
assemble these structures (Figure 10D). These results
lead us to conclude that activated Rho is required both
for the assembly of adherens junctions and for their
maintenance.
DISCUSSION
Several studies have provided evidence that Rho can
be a downstream effector of activated Ras (Ridley and
Hall, 1992; Khosravi-Far et al., 1995, 1996; Nobes and
Hall, 1995; Joneson et al., 1996; Marshall, 1996; Taylor
and Shalloway, 1996) and Rho plays an important role
in Ras transformation of fibroblasts (Prendergast et al.,
1995; Qiu et al., 1995b). In epithelial cells, oncogenic
Figure 7. Inhibition of Rho activity partially reverses the trans-
formed phenotype of Ras-transformed MCF10A cells. Ras-trans-
formed MCF10A cells were microinjected with coumarin-BSA
(A and B) or coumarin-BSA and 160 mg/ml C3 (C and D).
Twenty-five minutes after microinjection, the cells were fixed
and stained for vinculin (A and C) or visualized for coumarin-
BSA to reveal injected cells (B and D). Single examples of injected
cells are indicated with arrows. The arrowhead in C indicates
vinculin at the margin of a cell (in focal complexes). (E) Ras-
transformed MCF10A cells were microinjected with 160 mg/ml
C3 and propidium iodide to label the nuclei of injected cells. One
hour later, cells were permeabilized, fixed, and stained with
anti-E-cadherin antibody. Arrows indicate three injected cells.
Note the lack of E-cadherin staining between the injected cells.
Bar, 20 mm.
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Ras activation of the Raf/MAPK pathway alone is not
sufficient for full tumorigenic transformation, which
may indicate the possible involvement of other Ras-
related proteins (Oldham et al., 1996). How activated
Ras leads to activation of Rho is poorly understood. It
is possible that Ras may activate Rho via Ras-GTPase-
activating protein and/or phosphatidylinositol 3-ki-
nase (Settleman et al., 1992; Reif et al., 1996).
Ras-transformed MCF10A epithelial cells display
the hallmarks of activated Rho. These cells exhibit
prominent stress fibers and focal adhesions, whereas
their normal counterparts usually lack these struc-
tures. In addition, Ras-transformed epithelia have dis-
rupted cadherin-based adherens junctions (Kinch et
al., 1995). Previously this laboratory has shown that
the formation of stress fibers and focal adhesions in-
duced by Rho results, at least in part, from a stimula-
tion of contractility (Chrzanowska-Wodnicka and
Burridge, 1996). In this work, we set out to determine
whether the Ras-transformed epithelial phenotype re-
sults from Rho-mediated contractility. We have found
that Ras-transformed epithelia are indeed more con-
tractile than their nontransformed counterparts and
this contractility is blocked by inhibiting Rho with C3
exotransferase. The increased contractility of the Ras-
transformed epithelial cells is accompanied by an in-
crease in the level of myosin light chain phosphoryla-
tion. Others have shown that activated Rho can
elevate myosin light chain phosphorylation by two
pathways involving the Rho-activated kinase termed
Rho kinase. Rho kinase phosphorylates the myosin
phosphatase, thereby inhibiting it (Kimura et al., 1996).
The decreased phosphatase activity will elevate light
chain phosphorylation. In addition, Rho kinase has
been found to phosphorylate the regulatory light
chain directly (Amano et al., 1996) and to induce stress
fibers and focal adhesions when expressed in quies-
cent fibroblasts (Leung et al., 1996; Amano et al., 1997;
Ishizaki et al., 1997).
Several different inhibitors of contractility that act
on the myosin light chain kinase or on actin–myosin
interaction restore a more normal epithelial pheno-
Figure 8. Blocking Rho function by 19N-RhoA prevents focal adhesion formation but does not promote cell–cell adherens junction
formation. Ras-transformed MCF10A cells were microinjected into the nucleus with plasmid pGreen Lantern either alone (A and B) or with
a plasmid encoding 19N-RhoA (C and D). Twenty-four hours later, cells were fixed, permeabilized, and stained with antibody against vinculin
(A and C). Injected cells were visualized by expression of green fluorescent protein (B and D). Arrows indicate microinjected cells. Bar, 20
mm.
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type to the Ras-transformed epithelial cells. Previous
work has shown that inhibitors of contractility result
in a decrease in or loss of focal adhesions and stress
fibers (Volberg et al., 1994; Bershadsky et al., 1996;
Chrzanowska-Wodnicka and Burridge, 1996). With
the Ras-transformed epithelial cells, not only do
agents that inhibit contractility lead to a loss of stress
fibers and focal adhesions but they also restore a more
normal organization of E-cadherin. Disruption of ad-
herens junctions by chelation of extracellular calcium
can similarly be blocked by inhibition of contractility
(Citi et al., 1994; Volberg et al., 1994). In this earlier
work, it was concluded that the contractility within
cells contributed to the pulling apart of adherens junc-
tions that had been weakened by removal of calcium
from the cadherins that was involved in their ho-
mophilic interactions. Similarly, the increased contrac-
tility of the Ras-transformed MCF10A cells is likely to
contribute to the disruption of the adherens junctions.
However, Rho-induced contractility is unlikely to ac-
count for the complete Ras-transformed phenotype,
because introduction of constitutively activated Rho
seemed to be insufficient to mimic the Ras-trans-
formed cytoskeletal and junctional organization, and
inhibiting Rho activity in the Ras-transformed cells
did not restore normal adherens junctions. Other ef-
fects of Ras transformation must contribute to the
phenotype. One likely candidate is the increased ty-
rosine phosphorylation in these transformed cells,
which may affect junction integrity (Kinch et al., 1995).
A weakening of the links between E-cadherin and the
cytoskeleton due to tyrosine phosphorylation may
combine with the increased tension induced by acti-
vated Rho to disrupt the junctions.
We anticipated that blocking Rho function with C3
exotransferase or dominant negative 19N-RhoA would
restore a more normal phenotype. This was partially
true in that both C3 and 19N-RhoA caused a loss of
stress fibers and focal adhesions, as has been observed
with other cell types (Paterson et al., 1990). However,
when we examined the state of the junctions in C3-
injected cells, the situation was more complex. Al-
Figure 9. Introduction of constitutively active Rho into normal MCF10A cells is not sufficient to promote the formation of stress fibers.
Normal MCF10A cells were microinjected with either GST (A and B) or with 14V Rho-GST at 2.5 mg/ml (C and D) and returned to the
incubator for 7 h, followed by staining for GST (B and D) and actin (A and C). Arrows indicate microinjected cells. Bar, 20 mm.
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though vinculin appeared to have been translocated
from focal adhesions to adherens junctions (Figure
7C), we noted that the vinculin was prominent at the
free margins of the cells and at sites of cell–cell con-
tact. Examination of E-cadherin distribution revealed
that the adherens junctions had not been restored
(Figure 7E). The most likely interpretation of the vin-
culin organization in the C3-treated cells is that this
reflects the “Rac” phenotype and that the vinculin is in
“focal complexes” at the margins of the cells (Nobes
and Hall, 1995). Focal complexes contain many of the
same proteins as focal adhesions but are smaller struc-
tures found at the edge of lamellipodia or tips of
filopodia. Both Rac and Rho have been shown to be
downstream of Ras (Ridley et al., 1992; Khosravi-Far et
al., 1995; Qiu et al., 1995a,b), and so Rac would be
expected to be active in these Ras-transformed cells.
Blocking Rho activation with C3 has previously been
used to demonstrate Rac-induced lamellipodia, with
focal complexes at the distal tips of these structures
(Ridley et al., 1992; Nobes and Hall, 1995). Peripheral
focal complexes staining for vinculin were not seen in
cells expressing 19N-RhoA, possibly indicating that
this dominant negative form of Rho may also affect the
Rac pathway.
It is known that Rho controls a variety of actin-based
structures in addition to focal adhesions and stress
fibers. The inability of C3 to restore the epithelial
organization of E-cadherin led us to ask whether Rho
may also be needed for the normal assembly and
maintenance of adherens junctions. In this regard, it is
interesting that epitope-tagged Rho localizes to adhe-
rens junctions (Takaishi et al., 1995) and Rho has been
shown previously to be involved in the regulation of
tight junctions and the organization of perijunctional
actin (Nusrat et al., 1995; Ridley et al., 1995). We have
found that blocking Rho activity with C3 in normal
epithelial cells inhibits the assembly of adherens junc-
tions that are induced to form experimentally. More-
over, when C3 was introduced into epithelial cells that
Figure 10. Rho is required for the maintenance and formation of cell–cell adherens junctions in normal MCF10A cells. To examine the effect
of C3 on existing adherens junctions, normal MCF10A cells plated for 2 d were either injected with control buffer (A) or 100 mg/ml C3 (B).
To visualize the injected cells, the injection buffer contained propidium iodide to label the nuclei. After 30 min of incubation, cells were
permeabilized first, then fixed, and stained with E-cadherin. To examine the effect of C3 on the formation of adherens junctions, cells were
injected with buffer (C) or 100 mg/ml C3 (D), followed by addition of medium containing 4 mM ethylene glycol-bis(b-aminoethyl
ether)-N,N,N9,N9-tetraacetic acid for 30 min to disrupt the adherens junctions. Ca21 was then restored by changing the medium back to
normal for another 45 min. Cells were then permeabilized, fixed, and stained for E-cadherin. Bar, 20 mm.
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already had well formed adherens junctions, it led to
the disassembly of these structures. The E-cadherin
became more easily extracted in nonionic detergents,
presumably indicating a decreased association with
the cytoskeleton (Figure 10). How might Rho be reg-
ulating adherens junction assembly and integrity? It is
unlikely that this involves the stimulation of myosin
activity and contractility, because our data indicate
that inhibitors of contractility enhance adherens junc-
tion formation. Rho binds to and activates at least two
serine/threonine kinases, Rho kinase (Ishizaki et al.,
1996; Leung et al., 1996; Matsui et al., 1996) and protein
kinase N (Watanabe et al., 1996). In future work, it will
be interesting to determine whether any of the adhe-
rens junction proteins are direct substrates for these
kinases and whether serine/threonine phosphoryla-
tion of particular components enhances adherens
junction assembly or stability. Other potential targets
for the action of Rho in adherens junctions are mem-
bers of the ERM (ezrin, radixin, moesin) family of
proteins. These are found in adherens junctions and in
other locations where actin filaments interact with the
plasma membrane (Sato et al., 1992). Recent work has
indicated that interaction of ERM proteins with some
transmembrane proteins, such as CD44, is regulated
by Rho activity (Hirao et al., 1996). This may be via
phosphatidylinositol 4,5-bisphosphate, which was
also shown to regulate ERM–CD44 interactions (Hirao
et al., 1996). Consistent with the idea that Rho-medi-
ated ERM protein activity may be critical for adherens
junction integrity, perturbation of ERM proteins leads
to disruption of cell–cell interactions (Takeuchi et al.,
1994).
We conclude that in Ras-transformed epithelial
cells, downstream activation of Rho contributes to the
fibroblastic phenotype of these cells. The increased
contractility induced by Rho leads to the development
of stress fibers and focal adhesions and to the disrup-
tion of adherens junctions. However, high contractility
induced by Rho appears not to be sufficient for the
disruption of adherens junctions and probably other
events such as elevated tyrosine phosphorylation of
junctional components are required. Notably, we have
found that Rho activity is necessary for both the as-
sembly and maintenance of adherens junctions in nor-
mal cells.
Note. After submitting this work, Braga et al. (1997)
demonstrated that both Rho and Rac are required for
the assembly of adherens junctions in keratinocytes,
consistent with our findings.
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